about
Redox mechanisms in hepatic chronic wound healing and fibrogenesisRecent advances in managing chronic HCV infection: focus on therapy in patients with severe liver diseaseFour-dimensional flow magnetic resonance imaging in cirrhosis.Liver fibrosis: mechanisms of immune-mediated liver injuryModern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targetsPrognostic Value of a New Marker of Ventricular Repolarization in Cirrhotic PatientsMacrophage-mediated phagocytosis of apoptotic cholangiocytes contributes to reversal of experimental biliary fibrosis.Nitric oxide synthase and heme oxygenase expressions in human liver cirrhosisSimple tests to predict hepatic fibrosis in nonalcoholic chronic liver diseases.Liver cirrhosisA new conversation between radiology and pathology-identifying microvascular architecture in stages of cirrhosis via diffraction enhanced imaging in vitro.Staging of liver fibrosis or cirrhosis: The role of hepatic venous pressure gradient measurement.Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ.Losartan reduces trinitrobenzene sulphonic acid-induced colorectal fibrosis in rats.Liver lobe-based magnetic resonance diffusion-weighted imaging using multiple b values in patients with hepatitis B-related liver cirrhosis: association with the liver disease severity according to the Child-Pugh classNoninvasive diagnosis of fibrosis in chronic liver disease.Adenoviral delivery of truncated MMP-8 fused with the hepatocyte growth factor mutant 1K1 ameliorates liver cirrhosis and promotes hepatocyte proliferation.Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications.Human hepatic stellate cells are resistant to apoptosis: implications for human fibrogenic liver diseaseExtracellular matrix remodeling: the common denominator in connective tissue diseases. Possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure.Genesis of hepatic fibrosis and its biochemical markers.Prognostic value of Ishak fibrosis stage: findings from the hepatitis C antiviral long-term treatment against cirrhosis trial.Reversal of hepatic fibrosis: pathophysiological basis of antifibrotic therapies.Metrically measuring liver biopsy: a chronic hepatitis B and C computer-aided morphologic descriptionPharmacological inhibition of integrin alphavbeta3 aggravates experimental liver fibrosis and suppresses hepatic angiogenesis.The amazing universe of hepatic microstructure.Models and mechanisms of fibrosis resolution.Acute-on-chronic liver failure: current concepts on definition, pathogenesis, clinical manifestations and potential therapeutic interventions.Quantitative evaluation of liver cirrhosis using T1 relaxation time with 3 tesla MRI before and after oxygen inhalation.Achieving sustained virological response: what's the impact on further hepatitis C virus-related disease?Detrimental effects of nicotine on thioacetamide-induced liver injury in mice.Role of aetiology in the progression, regression, and parenchymal remodelling of liver disease: implications for liver biopsy interpretation.Assessment of Hepatic Impairment and Implications for Pharmacokinetics of Substance Use Treatment.Plumbagin Ameliorates CCl 4 -Induced Hepatic Fibrosis in Rats via the Epidermal Growth Factor Receptor Signaling Pathway.Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans.Sampling variability of computer-aided fractal-corrected measures of liver fibrosis in needle biopsy specimensTesting beneficial therapy in human cirrhosis using animal models of cirrhosis.Melittin attenuates liver injury in thioacetamide-treated mice through modulating inflammation and fibrogenesis.Reversal of liver fibrosis.Helicobacter pylori promotes hepatic fibrosis in the animal model.
P2860
Q24656684-5DB25C17-AB32-4ACE-9E7C-97E73F517DD0Q26752433-8548BA37-C846-4EAB-9B4D-A998E6851BBEQ26769606-3DD05D5A-F6F1-4ED2-90E1-0AFA51776B10Q27027766-019B04EF-0CD7-47DF-884B-D80D6ECDE83CQ28303698-B71A0EE2-19F6-4636-BDEA-6D4CC2F80EC6Q30100970-D7E49134-1F5C-40CF-B480-D038F7E4EECBQ33727374-C48998BD-79C7-419F-9777-118045814498Q33788328-3A41C54A-7AD8-4703-A7EB-AA81E4F7FB23Q33855796-91F51882-CFCB-4F24-995B-76C3EFF6C726Q34010340-E6CC5B0C-8838-45D6-9721-5776736AD936Q35087916-A350B30B-31BF-4591-9107-C1D929AA1A4AQ35237338-A9B0A6EE-FB97-449A-8CAD-2A992041F784Q35649446-3F6B2716-9DCC-48EC-9E64-507CD0BE6668Q35744613-39753659-8C95-4571-B0B5-E21BA50A1453Q35834155-A2EB2019-E057-49CC-93E9-4463DA592B60Q35878301-5147CC93-274F-41C9-8459-2CF019C095FEQ36208382-0484668D-E3BC-4189-9130-DEB49C8FCDEAQ36304061-36BDB1B7-1F0F-480D-930A-3E8C00759BC7Q36540031-F4D65A49-6BC5-469C-9D89-228FFFC37BE3Q36672445-4130B2EA-0833-40F4-873F-139B55247926Q37210050-1E3D9899-C8D7-4FC3-87F6-AC317476DD29Q37270537-3618E739-BB62-4E54-9CCC-DCB49F3BB97AQ37355850-BB0D2C7B-AF32-4E79-8338-B1DEB1123B6BQ37423058-D1668D74-4800-4B31-9F58-2829F96FB3F6Q37426714-37148D06-1716-4484-A0C0-2EF14AEAB4BFQ37566449-BBC0C6AC-E43F-4CA0-80E3-D32328D00309Q37834043-F8BF523B-DD62-4D38-86DF-13AB5BFD103AQ37903856-999BFA56-1856-4E16-B975-ED3804653A94Q37990892-803954D9-5AD6-4E19-AA35-9C3FE9022BAAQ38314738-8108BE85-E510-4A42-8922-D4973ED66DB4Q38706239-FF234B28-8EAA-4338-85F1-D86A36E56B6FQ38751392-CA93F883-11EA-4341-BFF4-2523984F4B0BQ38927192-6E50C782-F9AE-45F1-BCD6-15255810BA23Q40917613-6C4FF24D-2A1A-43EF-A106-0E56632DF22DQ42063388-1DFD2DE1-CAC8-4B9E-B037-F3A0C336FA64Q42068846-34E4517B-59A4-4815-B24F-0ED268EBEC72Q42699745-1E298FD8-A200-4801-BFF6-D8663774154BQ42726347-EC0C116B-8540-435F-AB50-E95C505BF551Q43104809-86462187-54F3-4FF5-82EE-E402897F7CE4Q43279775-7A02D4E4-1682-46AD-AC1C-5B69A2D0177A
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Cirrhosis reversal: a duel between dogma and myth.
@ast
Cirrhosis reversal: a duel between dogma and myth.
@en
type
label
Cirrhosis reversal: a duel between dogma and myth.
@ast
Cirrhosis reversal: a duel between dogma and myth.
@en
prefLabel
Cirrhosis reversal: a duel between dogma and myth.
@ast
Cirrhosis reversal: a duel between dogma and myth.
@en
P1476
Cirrhosis reversal: a duel between dogma and myth.
@en
P2093
Valeer J Desmet
P304
P356
10.1016/J.JHEP.2004.03.007
P577
2004-05-01T00:00:00Z